Cargando…

Saccharated ferric oxide attenuates haematopoietic response induced by epoetin beta pegol in patients undergoing haemodialysis

BACKGROUND: Decreased erythropoietin levels and impaired iron metabolism due to excessive hepcidin levels are responsible for renal anaemia in patients undergoing haemodialysis. Recently, erythroferrone (ERFE) has been identified as a factor that regulates hepcidin. In addition, fibroblast growth fa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iwasaki, Takahide, Fujimori, Akira, Nakanishi, Takeshi, Okada, Shioko, Hanawa, Nobuto, Hasuike, Yukiko, Kuragano, Takahiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034147/ https://www.ncbi.nlm.nih.gov/pubmed/33832448 http://dx.doi.org/10.1186/s12882-021-02320-2

Ejemplares similares

Induction of mesothelioma by intraperitoneal injections of ferric saccharate in male Wistar rats.
por: Okada, S., et al.
Publicado: (1989)

Oral Ferric Citrate Hydrate Associated With Less Oxidative Stress Than Intravenous Saccharated Ferric Oxide
por: Nakayama, Masaaki, et al.
Publicado: (2017)

Saccharated Calomel
Publicado: (1874)

Saccharated Calomel
por: Battey, Robert
Publicado: (1873)

Saccharated Calomel
por: Saxon, W. H.
Publicado: (1874)

Saccharated Calomel
por: Johnson, John M.
Publicado: (1874)

Saccharated Calomel
Publicado: (1874)

Epoetin beta pegol for treatment of anemia ameliorates deterioration of erythrocyte quality associated with chronic kidney disease
por: Aizawa, Ken, et al.
Publicado: (2018)

Should we reconsider iron administration based on prevailing ferritin and hepcidin concentrations?
por: Nakanishi, Takeshi, et al.
Publicado: (2012)

Saccharated Calomel, Again
por: May, M. R.
Publicado: (1874)

Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study
por: Kawabata, Hiroshi, et al.
Publicado: (2022)

Correction to: Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study
por: Kawabata, Hiroshi, et al.
Publicado: (2022)

On the Use of Saccharated Lime in Medicine
por: Cleland, John
Publicado: (1859)

Circadian Rhythm and CKD: Is Melatonin a Key Player or Bi-player?
por: Nagasawa, Yasuyuki, et al.
Publicado: (2019)

A Case of an Insufficiency Fracture of the Medial Proximal Tibia Secondary to Osteomalacia Associated with Long-Term Saccharated Ferric Oxide Administration
por: Ishimaru, Daichi, et al.
Publicado: (2017)

Epoetin beta pegol ameliorates flow‐mediated dilation with improving endothelial nitric oxide synthase coupling state in nonobese diabetic rats
por: Serizawa, Kenichi, et al.
Publicado: (2017)

A Case of Triplets—Saccharated Calomel
por: Whitaker, A. S.
Publicado: (1873)

A case of osteomalacia due to deranged mineral balance caused by saccharated ferric oxide and short-bowel syndrome: A case report
por: Nomoto, Hiroshi, et al.
Publicado: (2017)

Acetate free citrate-containing dialysate increase intact-PTH and BAP levels in the patients with low intact-PTH
por: Kuragano, Takahiro, et al.
Publicado: (2013)

Epoetin beta pegol alleviates oxidative stress and exacerbation of renal damage from iron deposition, thereby delaying CKD progression in progressive glomerulonephritis rats
por: Hirata, Michinori, et al.
Publicado: (2015)

Intravenous Iron Therapy with Saccharated Iron Oxide
por: Deshmukh, P. L.
Publicado: (1952)

Soluble Saccharated Oxide of Iron as an Antidote to Arsenic
Publicado: (1870)

Tolerability of Oral Supplementation with Microencapsulated Ferric Saccharate Compared to Ferrous Sulphate in Healthy Premenopausal Woman: A Crossover, Randomized, Double-Blind Clinical Trial
por: Friling, Marina, et al.
Publicado: (2022)

Epoetin β pegol (continuous erythropoietin receptor activator, CERA) is another choice for the treatment of anemia in myelodysplastic syndrome: a case report
por: Ikenoue, Tatsuyoshi, et al.
Publicado: (2017)

Antibody-mediated pure red cell aplasia related with epoetin-beta pegol (C.E.R.A.) as an erythropoietic agent: case report of a dialysis patient
por: Shingu, Yasuki, et al.
Publicado: (2020)

Pharmaceutical stability of colloidal saccharated iron oxide injection in normal saline
por: Hira, Daiki, et al.
Publicado: (2018)

Recombinant human epoetin beta in the treatment of renal anemia
por: Locatelli, Francesco, et al.
Publicado: (2007)

Epoetin beta for the treatment of chemotherapy-induced anemia: an update
por: Galli, Luca, et al.
Publicado: (2015)

A proposal of the simple guide regarding the conversion ratio from epoetin to darbepoetin alpha in treating haemodialysis patients with renal anaemia
por: Nakagawa, Tetsuya
Publicado: (2008)

Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trial
por: Carrera, Fernando, et al.
Publicado: (2010)

The Cost-Effectiveness of Continuous Erythropoiesis Receptor Activator Once Monthly versus Epoetin Thrice Weekly for Anaemia Management in Chronic Haemodialysis Patients
por: Maoujoud, Omar, et al.
Publicado: (2015)

Iron-induced calcification in human aortic vascular smooth muscle cells through interleukin-24 (IL-24), with/without TNF-alpha
por: Kawada, Sayuri, et al.
Publicado: (2018)

A Comparative Study of the Hemoglobin-Maintaining Effects Between Epoetin-β Pegol and Darbepoetin-α in Patients with Chronic Kidney Disease During 3 Months Before Dialysis Initiation
por: Oka, Satoru, et al.
Publicado: (2017)

Recombinant human epoetin beta in the treatment of chemotherapy-related anemia
por: Macpherson, Iain RJ, et al.
Publicado: (2009)

Potential hazards of recent trends in liberal iron use for renal anemia
por: Nakanishi, Takeshi, et al.
Publicado: (2020)

Randomised clinical trial of ferric citrate hydrate on anaemia management in haemodialysis patients with hyperphosphataemia: ASTRIO study
por: Yokoyama, Keitaro, et al.
Publicado: (2019)

Methoxy polyethylene glycol-epoetin beta for anemia with chronic kidney disease
por: Ohashi, Naro, et al.
Publicado: (2012)

Topical ocular delivery of nanoparticles with epoetin beta in Wistar Hannover rats
por: Silva, Beatriz, et al.
Publicado: (2023)

Quality of Original and Biosimilar Epoetin Products
por: Brinks, Vera, et al.
Publicado: (2010)

Transfusion-dependent anaemia treatment using continuous erythropoietin receptor activator (epoetin β pegol) and roxadustat after darbepoetin treatment failure in low-risk myelodysplastic syndrome: a case report
por: Ikenoue, Tatsuyoshi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o5d8pnn99rmjlb3gf62907tjeh